Literature DB >> 2901270

Comparison of large dose of vecuronium with pancuronium for prolonged neuromuscular blockade.

K Rørvik1, P Husby, L Gramstad, J S Vamnes, L Bitsch-Larsen, M E Koller.   

Abstract

Dose-duration relationships for vecuronium were determined and the duration of action produced by vecuronium 0.3 mg kg-1 shown to equal that of pancuronium 0.1 mg kg-1. Using these doses, the neuromuscular blocking properties and cardiovascular effects of the two drugs were compared. With large dose administration of vecuronium (0.3 mg kg-1), both the onset time (mean 81 s) and the 25-75% recovery index (mean 13.9 min) were about one-half those associated with pancuronium (mean 168.5 s and 29.3 min, respectively). The duration of action until 25% recovery was similar with both drugs. There was no evidence of cardiovascular instability with the large dose of vecuronium. Heart rate, however, was significantly slower (range 89.7-94.2% of control) 2-20 min after the injection of vecuronium. Vecuronium 0.3 mg kg-1 may have more favourable neuromuscular blocking effects than pancuronium 0.1 mg kg-1 and may be preferable to pancuronium when prolonged neuromuscular blockade is required.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901270     DOI: 10.1093/bja/61.2.180

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  9 in total

Review 1.  Newer neuromuscular blocking agents: how do they compare with established agents?

Authors:  H J Sparr; T M Beaufort; T Fuchs-Buder
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  A kinetic-dynamic model to explain the relationship between high potency and slow onset time for neuromuscular blocking drugs.

Authors:  F Donati; C Meistelman
Journal:  J Pharmacokinet Biopharm       Date:  1991-10

3.  Treatment with isoproterenol of bupivacaine toxicity.

Authors:  P Lacombe; G Blaise; F Plante; C Hollmann
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

4.  RE: Takaya et al. Optimum priming dose of vecuronium for tracheal intubation.J. Anesth (1996) 10:244-247.

Authors:  Hideo Nagashima
Journal:  J Anesth       Date:  1997-12       Impact factor: 2.078

5.  Different priming techniques, including mivacurium, accelerate the onset of rocuronium.

Authors:  M Naguib
Journal:  Can J Anaesth       Date:  1994-10       Impact factor: 5.063

6.  Optimum priming dose of vecuronium for tracheal intubation.

Authors:  Tetsuo Takaya; Hidekazu Kato; Mamoru Takiguchi
Journal:  J Anesth       Date:  1996-12       Impact factor: 2.078

7.  Haemodynamic effects of rocuronium during fentanyl anaesthesia: comparison with vecuronium.

Authors:  E P McCoy; V R Maddineni; P Elliott; R K Mirakhur; I W Carson; R A Cooper
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

8.  Duration of action of supplemental doses of vecuronium is related to the duration after the initial dose.

Authors:  T Otagiri; M Narita; M Nishizawa; C Nishimura
Journal:  J Anesth       Date:  1992-04       Impact factor: 2.078

9.  Neuromuscular effects of vecuronium and neostigmine in Montreal and Paris.

Authors:  Y Salib; J Frossard; B Plaud; B Debaene; C Meistelman; F Donati
Journal:  Can J Anaesth       Date:  1994-10       Impact factor: 5.063

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.